Five-decades-old diuretic drug may be viable for treating Alzheimer’s disease

USA – The National Institutes of Health (NIH) has reported that Bumetanide, a common and potent diuretic pill might hold the key to lowering the prevalence of Alzheimer’s disease, particularly in people who are genetically predisposed to the illness. The study included an analysis that found those who took Bumetanide, had a significantly lower prevalence of Alzheimer’s disease than those who did not. The study, which was funded by the National Institute on Aging (NIA), a branch of the National Institutes of Health, advances a precision medicine approach for people…

Read More